Mary Moonlight Italia

Dinafem announces Joint Venture in Italy with Mary Moonlight

  • Dinafem in collaboration with MML will brand a high quality canapa light product to be sold in Italy. 
  • The JV is on the long term and there will be new exciting products.
  • Both companies are aiming to play a leading role in the Italian market.
Mary Moonlight Italia

Dinafem, a globally leading cannabis seed and genetic company, is proud to announce that it has signed a deal with the Italian Cannabis light producing and selling company Mary Moonlight ( MML ) to start a Joint Venture ( JV ) where both companies will work together to market new exciting pure CBD genetics that will be of a higher quality than the currently existing available strains. That JV is exclusively focused on the Italian market and the aim is for both Dinafem and Mary Moonlight to become the most important players in that Italian market thanks to the experience Dinafem has with breeding new exciting strains.

From Dinafem we want to express our high confidence in the success of that JV and our pledge to dedicate all our available resources to become together with MML the main brand in that Italian market.

In the following months we will announce the next steps in that JV that will change the shape of the market for the better. We at Dinafem believe that once the public has the option to choose reputable high quality CBD products, with the backing of a solid brand behind them, many players will be forced to improve their game as the public will demand higher standards of quality and transparency. We also believe that companies making claims about strains with popular names will be under pressure to clarify the information about the products they are selling. We at Dinafem are looking forward for that environment of transparency and high quality as we believe we are better prepared than any other seed bank to compete with high quality products.

And after all, competition is good for the customers.

And we love competition!

08/09/2018

Comments from our readers

There are no comments yet. Would you like to be the first?

Leave a comment!

Contact us

x
Contact us